FDA expands access to MDMA as therapeutic treatment for PTSD The FDA's Expanded Access program will allow 50 patients to enroll in MDMA-assisted psychotherapy.
MDMA-assisted psychotherapy may be imminent: ‘We’re on track for MDMA to be approved by the FDA by 2021’ FDA is strongly considering full authorization of MDMA-assisted psychotherapy in 2021.
